Atlas Trials

RayzeBio, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch RayzeBio, Inc.

RecordFirmDate
Imaging Study in Metastatic Clear Cell RCC. (NCT07671417)RayzeBio, Inc.2026-06-01
Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC (NCT07671092)RayzeBio, Inc.2026-06-01
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. (NCT07165132)RayzeBio, Inc.2025-12-03
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC (NCT06726161)RayzeBio, Inc.2025-09-05
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. (NCT06590857)RayzeBio, Inc.2024-07-19
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC (NCT05595460)RayzeBio, Inc.2022-10-10
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (NCT05477576)RayzeBio, Inc.2022-03-24

Track RayzeBio, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.